Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ANAB

AnaptysBio (ANAB)

AnaptysBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANAB
DateTimeSourceHeadlineSymbolCompany
10/05/20229:00AMGlobeNewswire Inc.AnaptysBio and GSK-partnered immuno-oncology agents JEMPERLI (dostarlimab-gxly) and cobolimab show positive progress in two separate non-small cell lung cancer trialsNASDAQ:ANABAnaptysBio Inc
09/26/20228:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of DirectorsNASDAQ:ANABAnaptysBio Inc
09/16/20225:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
09/16/20225:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
09/12/20227:33AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
09/12/20227:30AMGlobeNewswire Inc.AnaptysBio Announces Sale of Zejula Royalties for Up To $45 MillionNASDAQ:ANABAnaptysBio Inc
09/09/20224:55PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ANABAnaptysBio Inc
08/31/20224:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
08/31/20224:15PMGlobeNewswire Inc.AnaptysBio Reports HARP Phase 2 Top-Line Data of Imsidolimab in Moderate-to-Severe Hidradenitis SuppurativaNASDAQ:ANABAnaptysBio Inc
08/09/20226:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
08/08/20225:02PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANABAnaptysBio Inc
08/08/20224:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
08/08/20224:05PMGlobeNewswire Inc.AnaptysBio Announces Second Quarter 2022 Financial Results and Provides Pipeline UpdateNASDAQ:ANABAnaptysBio Inc
08/05/20224:00PMGlobeNewswire Inc.AnaptysBio to Participate at the 2022 Wedbush PacGrow Healthcare Virtual ConferenceNASDAQ:ANABAnaptysBio Inc
06/27/20227:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
06/27/20227:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
06/24/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
06/10/20225:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
06/08/20228:13AMTipRanksThe Miracle Breakthrough Against Cancer & the Stocks That Stand to GainNASDAQ:ANABAnaptysBio Inc
06/02/20224:05PMGlobeNewswire Inc.AnaptysBio to Participate at the 2022 Jefferies Healthcare ConferenceNASDAQ:ANABAnaptysBio Inc
05/20/20224:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
05/12/20228:22AMTipRanksAnaptysBio (ANAB) Gets a Sell Rating from J.P. MorganNASDAQ:ANABAnaptysBio Inc
05/10/202212:09PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANABAnaptysBio Inc
05/04/20224:27PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANABAnaptysBio Inc
05/04/20224:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
05/04/20224:15PMGlobeNewswire Inc.AnaptysBio Announces First Quarter 2022 Financial Results and Provides Pipeline UpdateNASDAQ:ANABAnaptysBio Inc
04/29/20225:09PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANABAnaptysBio Inc
04/29/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
04/27/20224:15PMGlobeNewswire Inc.AnaptysBio Announces Positive ANB032 (anti-BTLA agonist) Top-Line Phase 1 Data and Provides Pipeline UpdatesNASDAQ:ANABAnaptysBio Inc
03/23/20224:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
 Showing the most relevant articles for your search:NASDAQ:ANAB